BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIVI BioVie Inc

交易中 10-22 14:38:08 EDT

1.26

+0.00

-0.40%

最高1.26	最低1.22	成交量7.50万
今开1.24	昨收1.26	日振幅3.57%
总市值1,090万	流通市值1,082万	总股本868.27万
成交额9.28万	换手率0.87%	流通股本861.80万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":1.255,"timestamp":1792694050579,"preClose":1.26,"halted":0,"volume":74950,"delay":0,"changeRate":-0.00396825396825406,"floatShares":8618000,"shares":8682700,"eps":-3.049999,"marketStatus":"交易中","change":-0.005,"latestTime":"10-22 14:38:08 EDT","open":1.24,"high":1.26,"low":1.215,"amount":92809.98539999999,"amplitude":0.035714,"askPrice":1.26,"askSize":300,"bidPrice":1.24,"bidSize":144,"shortable":3,"etf":0,"ttmEps":-3.049999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.2697,"preClose":1.26,"latestTime":"08:42 EDT","volume":2177,"amount":2912.9977653,"timestamp":1792672953851,"change":0.0097,"changeRate":0.007698,"amplitude":0.142857},"postHourTrading":{"tag":"盘后","latestPrice":1.2531,"preClose":1.26,"latestTime":"18:37 EDT","volume":601,"amount":753.72,"timestamp":1792622265464,"change":-0.0069,"changeRate":-0.005476,"amplitude":0.005476},"volumeRatio":0.430022,"impliedVol":1.6378,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BIVI/wiki","defaultTab":"wiki","newsList":[{"id":"1169556867","title":"BioVie公布Bezisterim治疗长新冠神经症状的2期ADDRESS-LC试验顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1169556867","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169556867?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:31","pubTimestamp":1789471911,"startTime":"0","endTime":"0","summary":"BioVie公司今日宣布，其评估Bezisterim用于治疗与长新冠相关神经症状的2期ADDRESS-LC临床试验已取得顶线结果。这一进展为该公司在神经科学领域的研发管线增添了新的重要数据点。BioVie公司表示，此次顶线结果的公布，标志着公司在探索针对长新冠神经症状治疗策略上迈出了关键一步。市场观察人士亦对此结果保持高度关注，视其为评估Bezisterim临床价值及BioVie公司未来前景的重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192350167","title":"BioVie宣布Bezisterim治疗长期新冠神经症状的ADDRESS-LC试验治疗阶段圆满完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1192350167","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192350167?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:02","pubTimestamp":1788177745,"startTime":"0","endTime":"0","summary":"BioVie Inc.今日宣告，其针对Bezisterim治疗长期新冠相关神经症状的ADDRESS-LC临床试验，已顺利走完治疗阶段全部流程。这一里程碑式的进展，标志着该候选药物在攻克新冠后遗症这一棘手领域迈出了坚实一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122397032","title":"BioVie Inc.旗下Bezisterim在运动与非运动症状改善方面展现显著统计优势，远超安慰剂组","url":"https://stock-news.laohu8.com/highlight/detail?id=1122397032","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122397032?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:33","pubTimestamp":1786016032,"startTime":"0","endTime":"0","summary":"BioVie Inc.宣布，其候选药物Bezisterim在临床试验中取得了突破性成果。与安慰剂对照组相比，该药物在改善患者运动及非运动症状方面，均展现出具有统计学意义的显著提升。这一发现，无疑为神经退行性疾病领域注入了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117468692","title":"BioVie二期试验达成预设终点：Bezisterim显著改善炎症与生物标志物","url":"https://stock-news.laohu8.com/highlight/detail?id=1117468692","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117468692?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:31","pubTimestamp":1786015883,"startTime":"0","endTime":"0","summary":"BioVie公司宣布，其二期临床试验成功达成预设终点。在本次试验中，候选药物Bezisterim展现出改善炎症指标及生物标志物的潜力。这一结果，无疑为后续研发工作注入了一剂强心针。试验数据表明，该药物在调整特定生物标记物水平方面表现积极，从而为炎症相关疾病的治疗策略提供了新的可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135112588","title":"BioVie Inc公布Bezisterim早期帕金森病2期Sunrise-Pd试验顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1135112588","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135112588?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:31","pubTimestamp":1786015882,"startTime":"0","endTime":"0","summary":"BioVie Inc近日宣布，其针对早期帕金森病（Parkinson's Disease）的候选药物Bezisterim，在名为Sunrise-Pd的2期临床试验中，取得了关键性顶线研究成果。这一消息引发了市场与医学界的广泛关注，为神经退行性疾病治疗领域注入了新的期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182736240","title":"BioVie宣布完成Bezisterim治疗长新冠相关神经症状的Address-Lc试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1182736240","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182736240?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:01","pubTimestamp":1779796880,"startTime":"0","endTime":"0","summary":"BioVie公司宣布，其针对Bezisterim治疗长新冠病毒感染相关神经症状的Address-Lc临床试验，现已完成全部患者的入组工作。该试验旨在评估候选药物对长新冠患者神经系统后遗症的潜在疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518224716","title":"Biovie Inc.盘中异动 早盘大幅跳水5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518224716?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Biovie Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报1.13美元/股，成交量4646股，换手率0.03%，振幅0.00%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a242f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a242f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516765199","title":"Biovie Inc.盘中异动 股价大跌5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516765199?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:57","pubTimestamp":1741024634,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时57分，Biovie Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报1.26美元/股，成交量9.4581万股，换手率0.51%，振幅4.50%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304015715a25d7c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304015715a25d7c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331748","title":"Biovie Inc.盘中异动 股价大跌5.59%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331748?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:35","pubTimestamp":1740684909,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时35分，Biovie Inc.股票出现异动，股价大幅跳水5.59%。截至发稿，该股报1.35美元/股，成交量13.516万股，换手率0.73%，振幅4.99%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280335099895481d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280335099895481d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514168970","title":"Biovie Inc.盘中异动 早盘股价大跌5.21%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514168970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514168970?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:27","pubTimestamp":1740497247,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时27分，Biovie Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报1.37美元/股，成交量12.8845万股，换手率0.70%，振幅6.24%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232728a2539489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232728a2539489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509011042","title":"Biovie Inc.盘中异动 快速下跌5.22%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509011042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509011042?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:52","pubTimestamp":1738860741,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时52分，Biovie Inc.股票出现异动，股价急速跳水5.22%。截至发稿，该股报1.91美元/股，成交量15.4829万股，换手率0.87%，振幅4.48%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005221961a2f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005221961a2f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509337662","title":"Biovie Inc.盘中异动 股价大涨5.11%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509337662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509337662?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:55","pubTimestamp":1738770932,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时55分，Biovie Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报1.83美元/股，成交量24.158万股，换手率1.36%，振幅6.75%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523553296191842&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523553296191842&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509989734","title":"Biovie Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509989734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509989734?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:01","pubTimestamp":1738695681,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时01分，Biovie Inc.股票出现异动，股价快速拉升5.31%。截至发稿，该股报1.69美元/股，成交量29.078万股，换手率1.64%，振幅6.87%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050301229618012a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050301229618012a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149370","title":"Biovie Inc.盘中异动 股价大跌10.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149370?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593216,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Biovie Inc.股票出现异动，股价大幅下挫10.17%。截至发稿，该股报1.48美元/股，成交量10.9718万股，换手率0.62%，振幅5.32%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223336abc10786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223336abc10786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507548842","title":"Biovie Inc.盘中异动 早盘大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507548842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507548842?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:58","pubTimestamp":1738079904,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时58分，Biovie Inc.股票出现波动，股价大幅跳水5.34%。截至发稿，该股报1.69美元/股，成交量16.3541万股，换手率0.92%，振幅7.02%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282358249875758a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282358249875758a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506656302","title":"Biovie Inc.盘中异动 临近午盘快速下跌5.70%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506656302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506656302?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:43","pubTimestamp":1737996196,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时43分，Biovie Inc.股票出现异动，股价快速下跌5.70%。截至发稿，该股报1.82美元/股，成交量15.7208万股，换手率0.88%，振幅3.63%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004316a231861c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004316a231861c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503234647","title":"Biovie Inc.盘中异动 早盘快速拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503234647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503234647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951606,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Biovie Inc.股票出现异动，股价大幅上涨5.59%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Allovir, Inc.、Cabaletta Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.53%、57.39%、35.56%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223326a222feaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223326a222feaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503944583","title":"Biovie Inc.盘中异动 早盘大幅跳水5.43%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503944583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503944583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736778976,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分，Biovie Inc.股票出现波动，股价大幅下挫5.43%。截至发稿，该股报2.09美元/股，成交量3.2677万股，换手率0.18%，振幅1.36%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3453.00%、2120.42%、393.12%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、61.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223616aba9324f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223616aba9324f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501077698","title":"Biovie Inc.盘中异动 早盘股价大跌5.26%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501077698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501077698?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:50","pubTimestamp":1736347819,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时50分，Biovie Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报2.34美元/股，成交量36.5795万股，换手率2.06%，振幅7.69%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225019aba35030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225019aba35030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500648635","title":"Biovie Inc.盘中异动 股价大跌5.25%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500648635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500648635?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:17","pubTimestamp":1735665470,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时17分，Biovie Inc.股票出现异动，股价大幅下挫5.25%。截至发稿，该股报1.98美元/股，成交量27.8952万股，换手率1.57%，振幅7.13%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101011751ab99a0cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101011751ab99a0cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioviepharma.com","stockEarnings":[{"period":"1week","weight":0.0862},{"period":"1month","weight":-0.227},{"period":"3month","weight":-0.125},{"period":"6month","weight":-0.16},{"period":"1year","weight":-0.3403},{"period":"ytd","weight":0.0862}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioVie Inc.成立于2013年4月10日，是一家内华达州公司。该公司是一家临床阶段的公司，致力于开发创新药物疗法，以治疗慢性衰弱疾病，包括神经和神经退行性疾病以及肝脏疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005325},{"month":2,"riseRate":0.5,"avgChangeRate":0.259645},{"month":3,"riseRate":0.625,"avgChangeRate":-0.036628},{"month":4,"riseRate":0.375,"avgChangeRate":0.025089},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.110348},{"month":6,"riseRate":0.555556,"avgChangeRate":0.426902},{"month":7,"riseRate":0.444444,"avgChangeRate":0.260814},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.130957},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.181566},{"month":10,"riseRate":0.333333,"avgChangeRate":0.159948},{"month":11,"riseRate":0.5,"avgChangeRate":-0.005666},{"month":12,"riseRate":0.25,"avgChangeRate":-0.131533}],"exchange":"NASDAQ","name":"BioVie Inc","nameEN":"BioVie Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioVie Inc,BIVI,BioVie Inc股票,BioVie Inc股票老虎,BioVie Inc股票老虎国际,BioVie Inc行情,BioVie Inc股票行情,BioVie Inc股价,BioVie Inc股市,BioVie Inc股票价格,BioVie Inc股票交易,BioVie Inc股票购买,BioVie Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}